Michael E. Lewis, Chief Scientific Advisor at Cara Therapeutics, Inc. (CARA), sold 14,524 shares at $10.93 ($159K) on 2016-01-26, disclosed to the SEC on 2016-01-27.
Open-market sale of $159k CARA by Chief Scientific Advisor. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.93 | 7,262 | $79K | 50.0% |
| 2 | $10.93 | 7,262 | $79K | 50.0% |
| Total | $10.93 avg | 14,524 | $159K | 100% |
| Filing → |
| CARA | SELL | 2015-05-05 | $77K | — | Filing → |
| CARA | SELL | 2015-04-02 | $72K | — | Filing → |
| CARA | SELL | 2015-03-03 | $73K | — | Filing → |